Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chahlavi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Gene Therapy|October 12, 1999
Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent miceA Chahlavi, S Rabkin, T Todo, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinomaA Chahlavi, T Todo, R L Martuza, et al.
Neurosurgery Clinics of North America|August 29, 2001
Adult-onset hydrocephalusA Chahlavi, S K El-Babaa, M G Luciano
Human Gene Therapy|December 10, 1999
Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapyT Todo, S D Rabkin, A Chahlavi, et al.
Journal of Clinical Pathology|March 1, 2005
Pathobiology of brain metastasesN Nathoo, A Chahlavi, G H Barnett, et al.
Molecular Pharmacology|August 1, 1996
Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotideT Yazaki, S Ahmad, A Chahlavi, et al.
Experimental Neurology|April 21, 2001
Therapeutic efficacy of G207 in a novel peripheral nerve sheath tumor modelG A Mashour, H D Moulding, A Chahlavi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Gene Therapy|October 12, 1999
Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent miceA Chahlavi, S Rabkin, T Todo, et al.
Neoplasia (New York, N.Y.)|August 10, 2000
Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinomaA Chahlavi, T Todo, R L Martuza, et al.
Neurosurgery Clinics of North America|August 29, 2001
Adult-onset hydrocephalusA Chahlavi, S K El-Babaa, M G Luciano
Human Gene Therapy|December 10, 1999
Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapyT Todo, S D Rabkin, A Chahlavi, et al.
Journal of Clinical Pathology|March 1, 2005
Pathobiology of brain metastasesN Nathoo, A Chahlavi, G H Barnett, et al.
Molecular Pharmacology|August 1, 1996
Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotideT Yazaki, S Ahmad, A Chahlavi, et al.
Experimental Neurology|April 21, 2001
Therapeutic efficacy of G207 in a novel peripheral nerve sheath tumor modelG A Mashour, H D Moulding, A Chahlavi, et al.
Pageof 1